Loading...

Reflect Scientific, Inc.

RSCFPNK
Healthcare
Medical - Instruments & Supplies
$0.05
$0.006(13.12%)
U.S. Market opens in 0h 54m

Reflect Scientific, Inc. Fundamental Analysis

Reflect Scientific, Inc. (RSCF) shows moderate financial fundamentals with a PE ratio of 19.94, profit margin of 12.99%, and ROE of 9.69%. The company generates $0.0B in annual revenue with strong year-over-year growth of 73.77%.

Key Strengths

Cash Position44.88%
PEG Ratio0.12
Current Ratio4.97

Areas of Concern

ROE9.69%
We analyze RSCF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 69.0/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
69.0/100

We analyze RSCF's fundamental strength across five key dimensions:

Efficiency Score

Weak

RSCF struggles to generate sufficient returns from assets.

ROA > 10%
7.47%

Valuation Score

Excellent

RSCF trades at attractive valuation levels.

PE < 25
19.94
PEG Ratio < 2
0.12

Growth Score

Moderate

RSCF shows steady but slowing expansion.

Revenue Growth > 5%
73.77%
EPS Growth > 10%
1.37%

Financial Health Score

Excellent

RSCF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.05
Current Ratio > 1
4.97

Profitability Score

Weak

RSCF struggles to sustain strong margins.

ROE > 15%
9.69%
Net Margin ≥ 15%
12.99%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is RSCF Expensive or Cheap?

P/E Ratio

RSCF trades at 19.94 times earnings. This indicates a fair valuation.

19.94

PEG Ratio

When adjusting for growth, RSCF's PEG of 0.12 indicates potential undervaluation.

0.12

Price to Book

The market values Reflect Scientific, Inc. at 1.84 times its book value. This may indicate undervaluation.

1.84

EV/EBITDA

Enterprise value stands at 24.06 times EBITDA. This signals the market has high growth expectations.

24.06

How Well Does RSCF Make Money?

Net Profit Margin

For every $100 in sales, Reflect Scientific, Inc. keeps $12.99 as profit after all expenses.

12.99%

Operating Margin

Core operations generate 10.34 in profit for every $100 in revenue, before interest and taxes.

10.34%

ROE

Management delivers $9.69 in profit for every $100 of shareholder equity.

9.69%

ROA

Reflect Scientific, Inc. generates $7.47 in profit for every $100 in assets, demonstrating efficient asset deployment.

7.47%

Following the Money - Real Cash Generation

Operating Cash Flow

Reflect Scientific, Inc. produces operating cash flow of $284.96K, showing steady but balanced cash generation.

$284.96K

Free Cash Flow

Reflect Scientific, Inc. generates strong free cash flow of $284.96K, providing ample flexibility for dividends, buybacks, or growth.

$284.96K

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

RSCF converts 6.82% of its market value into free cash.

6.82%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

19.94

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.12

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.84

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.59

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.05

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.97

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.10

vs 25 benchmark

ROA

Return on assets percentage

0.07

vs 25 benchmark

ROCE

Return on capital employed

0.07

vs 25 benchmark

How RSCF Stacks Against Its Sector Peers

MetricRSCF ValueSector AveragePerformance
P/E Ratio19.9428.96 Better (Cheaper)
ROE9.69%716.00% Weak
Net Margin12.99%-46137.00% (disorted) Strong
Debt/Equity0.050.35 Strong (Low Leverage)
Current Ratio4.974.52 Strong Liquidity
ROA7.47%-17407.00% (disorted) Weak

RSCF outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Reflect Scientific, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

7.72%

Industry Style: Defensive, Growth, Innovation

Growing

EPS CAGR

179.52%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ